Nielsen Carolyn M, White Matthew J, Goodier Martin R, Riley Eleanor M
Department of Immunology and Infection, London School of Hygiene and Tropical Medicine , London , UK.
Front Immunol. 2013 Dec 9;4:422. doi: 10.3389/fimmu.2013.00422.
Historically, human NK cells have been identified as CD3(-)CD56(+)CD16(±) lymphocytes. More recently it has been established that CD57 expression defines functionally discrete sub-populations of NK cells. On T cells, CD57 expression has been regarded as a marker of terminal differentiation and (perhaps wrongly) of anergy and senescence. Similarly, CD57 expression seems to identify the final stages of peripheral NK cell maturation; its expression increases with age and is associated with chronic infections, particularly human cytomegalovirus infection. However, CD57(+) NK cells are highly cytotoxic and their presence seems to be beneficial in a number of non-communicable diseases. The purpose of this article is to review our current understanding of CD57 expression as a marker of NK cell function and disease prognosis, as well as to outline areas for further research.
从历史上看,人类自然杀伤细胞(NK细胞)已被鉴定为CD3(-)CD56(+)CD16(±)淋巴细胞。最近已经确定,CD57的表达定义了NK细胞功能上离散的亚群。在T细胞上,CD57的表达被视为终末分化的标志物,并且(可能错误地)被视为无反应性和衰老的标志物。同样,CD57的表达似乎可以识别外周NK细胞成熟的最后阶段;其表达随年龄增长而增加,并与慢性感染有关,特别是人类巨细胞病毒感染。然而,CD57(+)NK细胞具有高度细胞毒性,它们的存在似乎在许多非传染性疾病中是有益的。本文的目的是回顾我们目前对CD57表达作为NK细胞功能和疾病预后标志物的理解,并概述进一步研究的领域。